A highly selective fluorescent probe for human NAD(P)H:quinone oxidoreductase 1 (hNQO1) detection and imaging in living tumor cells

17Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Human NAD(P)H:quinone oxidoreductase (hNQO1) can be used as a biomarker for the early diagnosis of cancer. In this article, a novel fluorescent probe 1 for detecting hNQO1 was designed and synthesized by using 2-dicyanomethylene-3-cyano-4,5,5-trimethyl-2,5-dihydrofuran (TCF) derivative (TCF-OH) as a fluorophore and quinone propionic acid (QPA) as a recognition group. The probe, which has high selectivity for hNQO1 and a Stokes shift of about 117 nm, shows a linear relationship with hNQO1 concentrations in the range of 0.25-3 μg ml-1 with the color changes from yellow to red and was successfully applied to intracellular hNQO1 imaging.

Cite

CITATION STYLE

APA

Zhu, Y., Han, J., Zhang, Q., Zhao, Z., Wang, J., Xu, X., … Zhang, J. (2019). A highly selective fluorescent probe for human NAD(P)H:quinone oxidoreductase 1 (hNQO1) detection and imaging in living tumor cells. RSC Advances, 9(46), 26729–26733. https://doi.org/10.1039/c9ra05650e

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free